IP Library Granted Patent US 8,148,119
Granted Patent B2
US 8,148,119 · App. 12/302,876 · Granted Apr 3, 2012

Hydroxylase gene and use thereof

Assignees: Microbiopharm Japan Co., Ltd.; National Institute of Advanced Industrial Science and Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,148,119
App. No.
12/302,876
Granted
Apr 3, 2012
Kind
B2
Abstract

A vitamin D 3 hydroxylase is purified from Pseudonocardia autotrophica cell, and a primer is designed based on amino acid sequence obtained from hydroxylase. Subsequently, PCR is conducted using genomic DNA of Pseudonocardia autotrophica as a template to clone a gene for the vitamin D 3 hydroxylase. By conducting a conversion reaction using a microorganism in which the vitamin D 3 hydroxylase gene is expressed using a proper expression system, a hydroxide of vitamin D or the like (e.g., hydroxy vitamin D 3 ) can be produced with high efficiency.

Claims (16)

1. An isolated polynucleotide encoding a hydroxylase selected from (a)-(c):

(a) an isolated polynucleotide comprising nucleotides 320-1531 of SEQ ID NO: 1; and

(b) an isolated polynucleotide that hybridizes under stringent conditions to a polynucleotide entirely complementary to nucleotides 320-1531 of SEQ ID NO: 1, wherein said hybridization under stringent conditions is hybridization at 65° C. in the presence of 0.7-1.0M sodium chloride; and

(c) an isolated polynucleotide comprising a polynucleotide sequence having at least 90% nucleic acid sequence identity to nucleotides 320-1531 of SEQ ID NO: 1.

2. An isolated host cell transformed with the polynucleotide of claim 1 .

3. The host cell of claim 2 , wherein said host cell is Escherichia coli or an actinomycete.

4. A method for producing a hydroxide of a vitamin D compound or 7-dehydrocholesterol, comprising:

(a) culturing the cell of claim 2 in a culture medium under conditions in which the polypeptide encoded by said polynucleotide is expressed; and

(b) contacting a vitamin D compound or 7-dehydrocholesterol with said culture medium, or with a purified extract of said culture medium containing said polypeptide, whereby a hydroxide of said vitamin D compound or 7-dehydrocholesterol is produced.

5. The method of claim 4 , wherein said cell further expresses redox partner proteins during said culturing.

6. The method of claim 4 , wherein the hydroxide of the vitamin D compound is 1α, 25-dihydroxy vitamin D 3 .

7. The method of claim 4 , wherein the hydroxide of the vitamin D compound is 25-dihydroxy vitamin D 3 .

8. The method of claim 4 , wherein the hydroxide of the vitamin D compound is 25-dihydroxy vitamin D 2 .

9. An isolated polynucleotide selected from (a) and (b):

(a) an isolated polynucleotide comprising a polynucleotide sequence encoding the amino acid sequence of SEQ ID NO: 2; and

(b) an isolated polynucleotide that hybridizes under stringent conditions to a polynucleotide entirely complementary to a polynucleotide encoding the amino acid sequence of SEQ ID NO: 2, wherein said hybridization under stringent conditions is hybridization at 65° C. in the presence of 0.7-1.0M sodium chloride, wherein the polynucleotide encodes a hydroxylase.

Assignments (6)
CHANGE OF ADDRESS Recorded Mar 4, 2022
From: MICROBIOPHARM JAPAN CO., LTD.
To: MICROBIOPHARM JAPAN CO., LTD.
Reel/Frame 059792/0794 →
CHANGE OF NAME AND ADDRESS Recorded Mar 4, 2022
From: MICROBIOPHARM JAPAN CO., LTD.
To: SANLI HOLDINGS CO., LTD.
Reel/Frame 059793/0517 →
SPLIT & SUCCESSION Recorded Mar 4, 2022
From: SANLI HOLDINGS CO., LTD.
To: MICROBIOPHARM JAPAN CO., LTD.
Reel/Frame 059318/0609 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2012
From: MERCIAN CORPORATION
To: MICROBIOPHARM JAPAN CO., LTD.
Reel/Frame 027558/0092 →
CORRECTIVE ASSIGNMENT TO CORRECT THE OMITTED PAGES OF THE ASSIGNMENT PREVIOUSLY RECORDED ON REEL 021954 FRAME 0690. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE: MERCIAN CORPORATION ASSIGNEE: NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY. Recorded Dec 16, 2008
From: FUJII, YOSHIKAZU; TAMURA, TOMOHIRO
To: MERCIAN CORPORATION; NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
Reel/Frame 021984/0217 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2008
From: FUJII, YOSHIKAZU; TAMURA, TOMOHIRO
To: MERCIAN CORPORATION; NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
Reel/Frame 021954/0690 →
Priority Claims (1)
JP 2006-150843 · May 31, 2006 · national
Continuity (1)
Related Publication 20100297712A1 · Nov 25, 2010